Inflammation is a natural marker for bodily health, and abnormal inflammatory response is indicated in an increasingly wide net of diseases and disorders, from cardiovascular disease and diabetes to major depression. Detect and quantitate inflammatory biomarkers with our wide range of in vivo, cellular, in situ, and biochemical inflammation research products.
Our products for inflammation research include:
- LANCE® TR-FRET technology for detection and quantitation of cytokines and other biomarkers
- AlphaLISA® Immunoassay kits for detection and quantitation of cytokines and other biomarkers
- DELFIA® (dissociation-enhanced lanthanide fluorescence immunoassay) TRF technology
- Cellular, tissue, and in vivo imaging systems
- Near-infrared (NIR) fluorescent and chemiluminescent in vivo imaging agents
- Target-specific radiolabeled ligands and receptor-transfected cell lines and membranes
- High content screening
This product portfolio meets the demands of many types of inflammation research:
- Quick and specific detection of inflammatory biomarkers in human and animal samples, including pro-inflammatory cytokines and chemokines like IL-8, IL-6, IL-2, IFN gamma, and TNF alpha and beta.
- Monitoring acute and pulmonary inflammation and therapeutic treatment in animal models in real time
- Phenotypic analysis
- Targeted studies in various sample types with high sensitivity and specificity
